Table 4.
Immunofluorescence findings in the studied 95 biopsy specimens
| Disease | IgG (%) | IgA (%) | IgM (%) | C3 (%) | C1q (%) | Fibrinogen (%) | Cases inadequate for IF | Total cases |
|---|---|---|---|---|---|---|---|---|
| LN | 31/31 (100) | 28/30 (94.1) | 31/32 (97) | 31/31 (100) | 28/30 (94.11) | 9/26 (37.5) | 3 | 34 |
| IgAN | 15/21 (71.4) | 22/22 (100) | 14/19 (73.6) | 17/21 (80.9) | 2/16 (12.5) | 3/15 (20) | 2 | 24 |
| PIGN | 14/15 (93.3) | 5/15 (33.3) | 10/15 (66.7) | 15/15 (100) | 2/8 (25) | 3/10 (30) | 1 | 16 |
| MPGN | 7/7 (100) | 2/7 (28.5) | 5/7 (71.4) | 7/7 (100) | 3/5 (60) | 1/5 (20) | 2 | 9 |
| C3 glomerulopathy | 0/7 (0) | 1/7 (14.2) | 2/7 (28.5) | 7/7 (100) | 1/7 (14.2) | 2/7 (28.5) | 0 | 7 |
| MPGN | 2/2 (100) | 0/2 (0) | 2/2 (100) | 2/2 (100) | 0/0 | 0/0 | 0 | 2 |
| DPGN | - | - | - | - | - | - | 3 | 3 |
DPGN: Diffuse proliferative glomerulonephritis, MPGN: Membranoproliferative glomerulonephritis, IF: Immunofluorescence, PIGN: Postinfectious glomerulonephritis, LN: Lupus nephritis, Ig: Immunoglobulin, IgAN: IgA nephropathy